Skip to main content

BOOTHBAY FUND MANAGEMENT, LLC

Position in RLMD — Relmada Therapeutics, Inc.

CIK 1549230 NEW YORK, NY

Position in RLMD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,908,132
-$1,166,090 QoQ
Shares Held
564,759
-22.5% QoQ
Ownership
0.529%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#35
of 126 holders
Holding Since
Mar 2021
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in RLMD Over Time

Shares Held

Position Value (USD)

Derivatives in RLMD

reported options exposure · as of Sep 30, 2022
CallValue
$5,053,230
CallShares
136,500
PutValue
$5,053,230
PutShares
136,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $666,641,771 across 159 Biotechnology names. RLMD ranks #39 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RLMD

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,908,132 564,759
2026-03-31 $5,074,222 729,055
2025-12-31 $4,034,499 835,300
2025-09-30 $1,393,404 693,236
2023-06-30 $31,468 12,792
2023-03-31 $28,909 12,792
2022-12-31 $44,644 12,792
2022-09-30 $5,053,230 136,500
2022-09-30 $5,053,230 136,500
2022-06-30 $727,317 38,300
2022-06-30 $691,236 36,400
2021-06-30 $1,099,639 34,353
2021-06-30 $752,235 23,500
2021-03-31 $1,169,359 33,211